SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SOROS who wrote (873)6/14/1998 5:19:00 PM
From: Wisee  Read Replies (1) of 1185
 
SOROS,

At these Boxing Day Sale prices, we have been accumulating more to our
position. We feel that with all the exciting drugs in Nortran's pipeline, it should be trading at a (minimum) market cap. of $100 million ($3/share).
Using Ernest/Young & Nesbitt/Burns evaluations, NRT should be trading
much higher than that.

There is no other stock out there that has the potential that Nortran has!!

We will continue to add to our position.

Wisee
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News